Junlong Dai

机构：Chinese University of Hong Kong, Sichuan University, West China Hospital of Sichuan University, Regend Therapeutics (China), University of Hong Kong

发表论文 21 篇 · 总被引 371 次 · h-index 8

代表论文

• IL‐6–induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma (2021 · Hepatology · 被引 137)
• Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection (2021 · Clinical Nutrition · 被引 40)
• An integrated map of fibroblastic populations in human colon mucosa and cancer tissues (2022 · Communications Biology · 被引 35)
• The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis (2020 · World Journal of Surgical Oncology · 被引 34)
• Baseline HBV‐DNA load plus AST/ALT ratio predicts prognosis of HBV‐related hepatocellular carcinoma after hepatectomy: A multicentre study (2021 · Journal of Viral Hepatitis · 被引 30)
• Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy (2021 · Chinese Medical Journal · 被引 23)